Form D — PharmaCyte Biotech, Inc.
0001683168-25-006676 · filed Sep 4, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $7,000,000
- Reported amount sold
- $7,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- PharmaCyte Biotech, Inc.
- CIK
- 1157075
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- —
- Address
- 3960 HOWARD HUGHES PARKWAY
LAS VEGAS, NV 89169 - Phone
- (917) 595.2850
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Joshua N. Silverman · Executive OfficerLAS VEGAS, NV Find on LinkedIn ↗
-
Carlos Trujillo · Executive OfficerLAS VEGAS, NV Find on LinkedIn ↗
-
Michael M. Abecassis · DirectorLAS VEGAS, NV Find on LinkedIn ↗
-
Robert Weinstein · DirectorLAS VEGAS, NV Find on LinkedIn ↗
-
Walker R. Wayne · DirectorLAS VEGAS, NV Find on LinkedIn ↗
-
Jonathan L. Schechter · DirectorLAS VEGAS, NV Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗